Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: J Hypertens. 2013 Apr;31(4):820–829. doi: 10.1097/HJH.0b013e32835e8227

TABLE 3.

Metabolic and endocrine parameters by treatment and salt sensitivity

Low salt High salt placebo High salt fenofibrate
Triglycerides (mg/dl)
 Salt-resistant 74.2 ± 34.1 76.6 ± 35.8 56.6 ± 28.3a,b
 Salt-sensitive 83.9 ± 31.8 82.4 ± 25.6 59.4 ± 18.1a,b
 All 78.6 ± 32.9 79.1 ± 31.4 57.8 ± 24.1a,b

Fasting glucose (mg/dl)
 Salt-resistant 92.4 ± 10.4 94.5 ± 12.6 93.3 ± 10.5
 Salt-sensitive 95.6 ± 11.4 92.6 ± 10.8 88.8 ± 6.9a
 All 93.8 ± 10.8 93.5 ± 11.6 91.3 ± 9.3

Weight (kg)
 Salt-resistant 82.6 ± 17.3 83.0 ± 17.0 83.0 ± 17.4
 Salt-sensitive 91.5 ± 27.1 92.5 ± 26.3 92.1 ± 26.5
 All 86.6 ± 22.3 87.3 ± 21.9a 87.1 ± 22.0a

Urinary sodium (mmol/day)
 Salt-resistant 28.0 ± 24.5 187.1 ± 74.5a 181.8 ± 74.2a
 Salt-sensitive 21.4 ± 13.8 204.9 ± 73.5a 216.0 ± 70.5a
 All 25.0 ± 20.3 195.1 ± 73.4a 197.2 ± 73.4a

Urinary potassium (mmol/day)
 Salt-resistant 79.6 ± 16.8 90.2 ± 30.9 101.3 ± 31.5a
 Salt-sensitive 67.5 ± 19.9 96.2 ± 40.8a 97.9 ± 40.3a
 All 74.1 ± 18.9 92.9 ± 35.2a 99.8 ± 35.1a

Urine creatinine (g/day)
 Salt-resistant 1.41 ± 0.45 1.33 ± 0.36 1.26 ± 0.44
 Salt-sensitive 1.66 ± 0.57 1.50 ± 0.71 1.40 ± 0.62
 All 1.53 ± 0.51 1.41 ± 0.55 1.32 ± 0.52a

Aldosterone (pg/ml)
 Salt-resistant 164.7 ± 75.8 76.8 ± 32.7a 81.2 ± 40.5a
 Salt-sensitive 141.6 ± 59.9 64.6 ± 20.6a 63.8 ± 19.3a
 All 154.2 ± 68.9 71.3 ± 28.1a 73.6 ± 33.7a

PRA (ng Ang l/ml per h)
 Salt-resistant 3.7 ± 3.1 0.78 ± 0.60a 0.67 ± 0.41a
 Salt-sensitive 2.5 ± 1.7 0.71 ± 0.65a 0.51 ± 0.46a,b
 All 3.2 ± 2.6 0.75 ± 0.62a 0.60 ± 0.44a

Plasma norepinephrine (pg/ml)
 Salt-resistant 244.1 ± 83.5 173.8 ± 79.3a 192.5 ± 112.2a
 Salt-sensitive 260.1 ± 94.5 176.6 ± 93.9a 176.2 ± 80.0a
 All 251.3 ± 87.5 175.1 ± 84.9a 185.4 ± 98.3a

Urine DHPG (μg/day)
 Salt-resistant 134.7 ± 118.3 40.1 ± 23.9a 64.5 ± 57.1a,b
 Salt-sensitive 85.1 ± 45.8 47.9 ± 31.1a 43.8 ± 32.9a
 All 112.3 ± 94.9 43.6 ± 27.2a 55.1 ± 48.1a

Urine norepinephrine (μg/day)
 Salt-resistant 133.1 ± 141.2 33.8 ± 34.0a 58.4 ± 88.8a
 Salt-sensitive 93.4 ± 117.9 33.2 ± 33.3a 34.5 ± 46.8a
 All 115.2 ± 130.6 33.5 ± 33.1a 47.6 ± 72.8a

Urine epinephrine (μg/day)
 Salt-resistant 17.3 ± 35.4 4.1 ± 4.0 8.1 ± 8.4b
 Salt-sensitive 8.3 ± 7.2 6.6 ± 11.3 3.8 ± 3.9a
 All 13.2 ± 26.7 5.2 ± 8.1 6.2 ± 7.0

Urine dopamine (μg/day)
 Salt-resistant 560.0 ± 717.1 167.3 ± 113.7a 234.3 ± 171.9
 Salt-sensitive 346.0 ± 249.5 200.9 ± 118.8a 166.0 ± 129.9a
 All 463.3 ± 559.4 182.5 ± 115.4a 203.5 ± 115.8a

Data presented as N or mean ± SD. DHPG, dihydroxylphenylglycol; PRA, plasma renin activity.

a

P <0.05 versus low salt.

b

P <0.05 versus high salt placebo.